⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN UPLIZNA ® ДЛЯ ЛЕЧЕНИЯ ГЕНЕРАЛИЗОВАННОЙ МИАСТЕНИИ USA - Pусский USA - English USA - español USA - Français USA - Polski USA - čeština
prnewswire.com
AMGN
EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK UPLIZNA® SPOLEČNOSTI AMGEN PRO GENERALIZOVANOU MYASTENII GRAVIS USA - čeština USA - English USA - español USA - Français USA - Polski
prnewswire.com
AMGN
KOMISJA EUROPEJSKA ZATWIERDZA LEK UPLIZNA® FIRMY AMGEN W LECZENIU UOGÓLNIONEJ MIASTENII USA - Polski USA - español USA - Français USA - English
prnewswire.com
AMGN
BCL-2 Inhibitors Market Poised for Robust Growth During the Forecast Period (2025-2034) as Oncology Pipelines Expand | DelveInsight
prnewswire.com
ABBV
AMGN
AZN
BMY
GILD
JNJ
LLY
MRK
NVS
PFE
SNY
TMO
LA COMMISSION EUROPEENNE APPROUVE UPLIZNA® D'AMGEN DANS LE CADRE DU TRAITEMENT DE LA MYASTHÉNIE GRAVE GÉNÉRALISÉE USA - Français USA - English USA - español
prnewswire.com
AMGN
La Comisión Europea aprueba UPLIZNA® de Amgen para la miastenia gravis generalizada USA - español USA - English
prnewswire.com
AMGN
Levelpath's Breakout Year Sets Stage for Charles Giardina Appointment as VP of Engineering
businesswire.com
SIRI
AMGN
CPNG
Visier Reveals 2026 Partner of the Year Award Winners
prnewswire.com
AMZN
AMGN
EBAY
F
EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS
prnewswire.com
AMGN
Asthma Drugs Market to Reach USD 41.18 Billion by 2035 | Biologic Therapies Accelerate Shift Toward Targeted Treatment Says Astute Analytica
globenewswire.com
SNY
AMGN
AZN
GSK
TEVA
CHKP